Considering that BTK and immunoglobulin form BCR signaling, this comprehensive decrease suggests a downregulation of BCR signaling, which may be responsible for the immune phenotype of CD5-positive DLBCL. Here, BTK is linked to diffuse large B-cell lymphoma.